The limb girdle muscular dystrophies: Our ever-expanding knowledge

Journal of Clinical Neuromuscular Disease

Volumn 5, Issue 1, 2003, Pages 12-28

  Wicklund, Matthew P ^a   Mendell, Jerry R ^b  

^a WILFORD HALL MEDICAL CENTER   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Calpain; Caveolin; Dysferlin; Fukutin related protein; Lamin A C; Limb girdle; Muscular dystrophy myotilin; Sarcoglycan; Telethonin; Titin0; TRIM 32

Indexed keywords

ADENOVIRUS VECTOR; CALPAIN 3; CAVEOLIN 3; CONNECTIN; CREATINE KINASE; DYSFERLIN; GENE PRODUCT; LAMIN A; LAMIN B; PHENYTOIN; SARCOGLYCAN; TOCAINIDE;

AUTOSOMAL DOMINANT INHERITANCE; AUTOSOMAL RECESSIVE INHERITANCE; CARDIOMYOPATHY; CLINICAL FEATURE; CONGESTIVE CARDIOMYOPATHY; DIAGNOSTIC ACCURACY; DISEASE CLASSIFICATION; DYSARTHRIA; EXERCISE; GENE LOCUS; GENE MUTATION; GENE TRANSFER; GENETIC LINKAGE; GENETIC VARIABILITY; HUMAN; IMMUNOHISTOCHEMISTRY; LABORATORY TEST; LIMB GIRDLE MUSCULAR DYSTROPHY; LIPODYSTROPHY; MUSCLE BIOPSY; MYOTONIA; NONHUMAN; NUTRITIONAL SUPPORT; ONSET AGE; ORTHOPEDIC EQUIPMENT; PATIENT MONITORING; PHENOTYPE; PHYSIOTHERAPY; PRIORITY JOURNAL; PROTEIN ANALYSIS; REVIEW; VIRAL GENE DELIVERY SYSTEM;

EID: 1642566760     PISSN: 15220443     EISSN: None     Source Type: Journal    
DOI: 10.1097/00131402-200309000-00003     Document Type: Review

References (124)

1. Walton JN, Nattrass FJ. On the classification, natural history and treatment of the myopathies. Brain. 1954;77:169-231.
2. Cohn RD, Campbell KP. Molecular basis of muscular dystrophies. Muscle Nerve. 2000;23:1456-1471.
3. Bushby KMD. Diagnostic criteria for the limb-girdle muscular dystrophies: Report of the ENMC consortium on limb-girdle dystrophies. Neuromuscul Disord. 1995;5:71-74.
4. Bushby KMD, Beckmann JS. The limb-girdle muscular dystrophies-proposal for a new nomenclature. Neuromuscul Disord. 1995;5:337-343.
5. Gilchrist JM, Pericak-Vance M, Silverman L, et al. Clinical and genetic investigation in autosomal dominant limb-girdle muscular dystrophy. Neurology. 1988;38:5-9.
6. Hauser MA, Horrigan SK, Salmikangas P, et al. Myotilin is mutated in limb girdle muscular dystrophy 1A. Hum Mol Genet. 2000;9:2141-2147.
7. Feit H, Silbergleit A, Schneider LB, et al. Vocal cord and pharyngeal weakness with autosomal dominant distal myopathy: Clinical description and gene localization to 5q31. Am J Hum Genet. 1998;63: 1732-1742.
8. Cao H, Hegele RA. Nuclear lamin A/C R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophy. Hum Mol Genet. 2000; 9:109-112.
9. De Sandre-Giovannoli A, Chaouch M, Kozlov S, et al. Homozygous defects in LMNA, encoding lamin A/C nuclear envelop proteins, cause amosomal recessive axonal neuropathy in human (Charcot-Marie-Tooth disorder type 2) and mouse. Am J Hum Genet. 2002;70:726-736.
10. Novelli G, Muchir A, Sangiuolo F, et al. Mandibuloacral dysplasia is caused by a mutation in LMNA-encoding lamin A/C. Am J Hum Genet. 2002;71: 426-431.
11. Muchir A, Bonne G, van der Kooi A, et al. Identification of mutations in the gene encoding lamins A/C in autosomal dominant limb girdle muscular dystrophy with atrioventricular conduction disturbances (LGMD1B). Hum Mol Genet. 2000;9:1453-1459.
12. Bonne G, Di Barletta MR, Varnous S, et al. Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy. Nat Genet. 1999;21:285-288.
13. Fatkin D, MacRae C, Sasaki T, et al. Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. N Engl J Med. 1999;341:1715-1724.
14. Emery AEH. Emery-Dreifuss muscular dystrophy-a 40 year retrospective. Neuromuscul Disord. 2000; 10:228-232.
15. Brodsky GL, Muntoni F, Miocic S, et al. Lamin A/C gene mutation associated with dilated cardiomyopathy with variable skeletal muscle involvement. Circulation. 2000;101:473-476.
16. van der Kooi AJ, Bonne G, Eymard B, et al. Lamin A/C mutations with lipodystrophy, cardiac abnormalities, and muscular dystrophy. Neurology. 2002;59:620-623.
17. Bonne G, Mercuri E, Muchir A, et al. Clinical and molecular spectrum of autosomal dominant Emery-Dreifuss muscular dystrophy due to mutations of the lamin A/C gene. Ann Neurol. 2000;48:170-180.
18. Sewry CA, Brown SC, Mercuri E, et al. Skeletal muscle pathology in autosomal dominant Emery-Dreifuss muscular dystrophy with lamin A/C mutations. Neuropathol Appl Neurobiol. 2001;27:281-290.
19. Minetti C, Sotgia F, Bruno C, et al. Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy. Nat Genet. 1998;18: 365-368.
20. Betz RC, Schoser BGH, Kasper D, et al. Mutations in CAV3 cause mechanical hyperirritability of skeletal muscle in rippling muscle disease. Nat Genet. 2001;28:218-219.
21. Carbone I, Bruno C, Sotgia F, et al. Mutation in the CAV3 gene causes partial caveolin-3 deficiency and hyperCKemia. Neurology. 2000;54:1373-1376.
22. Tateyama M, Aoki M, Nishino I, et al. Mutation in the caveolin-3 gene causes a peculiar form of distal myopathy. Neurology. 2002;58:323-325.
23. Fischer D, Schroers A, Blümcke I, et al. Consequences of a novel caveolin-3 mutation in a large German family. Ann Neurol. 2003;53:233-241.
24. Galbiati F, Razani B, Lisanti M. Emerging themes in lipid rafts and caveolae. Cell. 2001;106:403-411.
25. Marx J. Caveolae: A once elusive structure gets some respect. Science. 2001;294:1862-1865.
26. Galbiati F, Razani B, Lisanti M. Caveolae and caveolin-3 in muscular dystrophy. Trends Mol Med. 2001;7:435-441.
27. Crosbie RH, Yamada H, Venzke DP, et al. Caveolin-3 is not an essential component of the dystrophin glycoprotein complex. FEBS Lett. 1998;427: 279-282.
28. Herrmann R, Straub V, Blank M, et al. Dissociation of the dystroglycan complex in caveolin-3-deficient limb girdle muscular dystrophy. Hum Mol Genet. 2000;9:2335-2340.
29. Matsuda C, Hayashi Y, Ogawa M, et al. The sarcolemmal proteins dysferlin and caveolin-3 interact in skeletal muscle. Hum Mol Genet. 2001;17:1761-1766.
30. Galbiati F, Engelman JA, Volante D, et al. Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex, and T-tubule abnormalities. J Biol Chem. 2001;276:21425-21433.
31. Minetti C, Bado M, Broda P, et al. Impairment of caveolae formation and T-system disorganization in human muscular dystrophy with caveolin-3 deficiency. Am J Pathol. 2002;160:265-270.
32. Ricker K, Moxley RT, Rohkamm R. Rippling muscle disease. Arch Neurol. 1989;46:405-408.
33. Vorgerd M, Bolz H, Patzold T, et al. Phenotypic variability in rippling muscle disease. Neurology. 1999;52:1453-1459.
34. Merlini L, Carbone I, Capanni C, et al. Familial isolated hyperCKemia associated with a new mutation in the caveolin-3 (CAV-3) gene. J Neurol Neurosurg Psychiatry. 2002;73:65-67.
35. So YT, Zu L, Barraza C, et al. Rippling muscle disease: evidence for phenotypic and genetic heterogeneity. Muscle Nerve. 2001;24:340-344.
36. Torbergsen T. Rippling muscle disease: A review. Muscle Nerve. 2002;11:S103-S107.
37. Galbiati F, Volonté D, Minetti C, et al. Limb-girdle muscular dystrophy (LGMD1C) mutants of caveolin-3 undergo ubiquitination and proteasomal degradation. J Biol Chem. 2000;275:37702-37711.
38. Shaw T, Elliott P, McKenna WJ. Dilated cardiomyopathy: A genetically heterogeneous disease. Lancet. 2002;360:654-655.
39. Messina DN, Speer MC, Pericak-Vance MA, et al. Linkage of familial dilated cardiomyopathy with conduction defect and muscular dystrophy to chromosome 6q23. Am J Hum Genet. 1997;61:909-917.
40. Schneiderman LJ, Sampson WI, Schoene WC, et al. Genetic studies of a family with two unusual autosomal dominant conditions: muscular dystrophy and Pelger-Huet anomaly. Am J Med. 1969;46:380-393.
41. Speer MC, Gilchrist JM, Chutkow JG, et al. Evidence for locus heterogeneity in autosomal dominant limb-girdle muscular dystrophy. Am J Med Genet. 1995;57:1371-1376.
42. Speer MC, Vance JM, Grubber JM, et al. Identification of a new autosomal dominant limb-girdle muscular dystrophy locus on chromosome 7. Am J Hum Genet. 1999;64:556-562.
43. McBride TI. Paget's disease and muscular dystrophy: Report of an unusual association in one family. Scott Med J. 1966;11:238-243.
44. Gutman AB, Kasabach H. Paget's disease (osteitis deformans). Analysis of 116 cases. Am J Med Sci. 1936;191:361-380.
45. Kimonis VE, Kovach MJ, Waggoner B, et al. Clinical and molecular studies in a unique family with autosomal dominant limb-girdle muscular dystrophy and Paget disease of bone. Genet Med. 2000;2:232-241.
46. Kovach MJ, Waggoner B, Leal SM, et al. Clinical delineation and localization to chromosome 9p13.3-p12 of a unique dominant disorder in four families: Hereditary inclusion body myopathy, Paget disease of bone, and frontotemporal dementia. Mol Genet Metab. 2001;74:458-475.
47. Waggoner B, Kovach MJ, Winkelman M, et al. Heterogeneity in familial dominant Paget disease of bone and muscular dystrophy. Am J Med Genet. 2002;108:187-191.
48. Edström L, Thornell L-E, Albo J, et al. Myopathy with respiratory failure and typical myofibrillar lesions. J Neurol Sci. 1990;96:211-228.
49. Nicolao P, Xiang F, Gunnarsson L-G, et al. Autosomal dominant myopathy with proximal weakness and early respiratory muscle involvement maps to chromosome 2q. Am J Hum Genet. 1999;64:788-792.
50. Xiang F, Nicolao P, Chapon F, et al. A second locus for autosomal dominant myopathy with proximal muscle weakness and early respiratory muscle involvement: A likely chromosomal locus on 2q21. Neuromuscul Disord. 1999;9:308-312.
51. Gamez J, Navarro C, Andreu AL, et al. Autosomal dominant limb-girdle muscular dystrophy: A large kindred with evidence for anticipation. Neurology. 2001;56:450-454.
52. Tanaka K, Yamada T, Kikuchi H, et al. Autosomal dominant limb-girdle muscular dystrophy with ankle joint contractures. Acta Neurol Scand. 1999; 100:199-201.
53. Bushby KMD. The limb-girdle muscular dystrophies-multiple genes, multiple mechanisms. Hum Mol Genet. 1999;8:1875-1882.
54. Chou F-L, Angelini C, Daentl D, et al. Calpain III mutation analysis of a heterogeneous limb-girdle muscular dystrophy population. Neurology. 1999; 52:1015-1020.
55. Chae J, Minami N, Jin Y, et al. Calpain 3 gene mutations: genetic and clinico-pathologic findings in limb-girdle muscular dystrophy. Neuromuscul Disord. 2001;11:547-555.
56. Zatz M, Vainzof M, Passos-Bueno MR. Limb-girdle muscular dystrophy: One gene with different phenotypes, one phenotype with different genes. Curr Opin Neurol. 2000;13:511-517.
57. Fardeau M, Hillaire D, Mignard C, et al. Limb-girdle muscular dystrophies frequent in Réunion Island [Abstract]. Proceedings of the XIVth World Congress of Neurology, October 22-27, 1989. Neurol India. 1989;37:SUpplement.
58. Beckmann JS, Richard I, Hillaire D, et al. A gene for limb-girdle muscular dystrophy maps to chromosome 15 by linkage. C R Acad Sci III. 1991;312: 114-118.
59. Richard I, Bronx O, Allamand V, et al. A novel mechanism leading to muscular dystrophy: Mutations in calpain 3 cause limb-girdle muscular dystrophy type 2A. Cell. 1995;81:27-40.
60. Fardeau M, Hillaire D, Mignard C, et al. Juvenile limb-girdle muscular dystrophy: Clinical, histopathological and genetic data from a small community living in the Reunion Island. Brain. 1996;119:295-308.
61. Pollitt C, Anderson LVB, Pogue R, et al. The phenotype of calpainopathy: Diagnosis based on a multidisciplinary approach. Neuromuscul Disord. 2001;11:287-296.
62. Dirik E, Aydin A, Kurul S, et al. Limb girdle muscular dystrophy type 2A presenting with cardiac arrest. Pediatr Neurol. 2001;24:235-237.
63. Talim B, Ognibene A, Mattioli E, et al. Normal calpain expression in genetically confirmed limb-girdle muscular dystrophy type 2A. Neurology. 2001;56:692-693.
64. Richard I, Roudaut C, Saenz A, et al. Calpainopathy-a survey of mutations and polymorphisms. Am J Hum Genet. 1999;64:1524-1540.
65. Bushby KMD, Beckmann JS. The 105th ENMC sponsored workshop: pathogenesis in the non-sarcoglycan timb-girdle muscular dystrophies, Naarden; April 12-14, 2002. Neuromuscul Disord. 2003;13:80-90.
66. Tagawa K, Taya C, Hayashi Y, et al. Myopathy phenotype of transgenic mice expressing active sitemutated inactive p94 skeletal muscle-specific calpain, the gene product responsible for limb girdle muscular dystrophy type 2A. Hum Mol Genet. 2000;9:1393-1402.
67. Baghdiguian S, Martin M, Richard I, et al. Calpain 3 deficiency is associated with myonuclear apoptosis and profound perturbation of the IκBα /NF-κB pathway in limb-girdle muscular dystrophy type 2A. Nat Med. 1999;5:503-511.
68. Udd B, Kääriänen H, Somer H. Muscular dystrophy with separate clinical phenotypes in a large family. Muscle Nerve. 1991;14:1050-1058.
69. Mahjneh I, Vannelli G, Bushby K, et al. A large inbred Palestinian family with two forms of muscular dystrophy. Neuromuscul Disord. 1992;2: 277-283.
70. Illarioshkin SN, Ivanova-Smolenskaya IA, Tanaka H, et al. Clinical and molecular analysis of a large family with three distinct phenotypes of progressive muscular dystrophy. Brain. 1996;119:1895-1909.
71. Weiler T, Greenberg CR, Nylen E, et al. Limb-girdle muscular dystrophy and Miyoshi myopathy in an aboriginal Canadian kindred map to LGMD2B and segregate with the same haplotype. Am J Hum Genet. 1996;59:872-878.
72. Liu J, Aoki M, Illa I, et al. Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy. Nat Genet. 1998; 20:31-36.
73. Illarioshkin SN, Ivanova-Smolenskaya IA, Greenberg CR, et al. Identical dysferlin mutation in limb-girdle muscular dystrophy type 2B and distal myopathy. Neurology. 2000;55:1931-1933.
74. Bashir R, Britton S, Strachan T, et al. A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B. Nat Genet. 1998;20:37-42.
75. Achanzar WE, Ward S. A nematode gene required for sperm vesicle fusion. J Cell Sci. 1997;110:1073-1081.
76. Illa I, Serrano-Munuera C, Gallardo E, et al. Distal anterior compartment myopathy: A dysferlin mutation causing a new muscular dystrophy phenotype. Ann Neurol. 2001;49:130-134.
77. Argov Z, Sadeh M, Mazor K, et al. Muscular dystrophy due to dysferlin deficiency in Libyan Jews. Brain. 2000;123:1229-1237.
78. Mahjneh I, Marconi G, Bushby K, et al. Dysferlinopathy (LGMD2B): A 23-year follow-up study of 10 patients homozygous for the same frameshifting dysferlin mutations. Neuromuscul Disord. 2001; 11:20-26.
79. Saperstein DS, Amato AA, Barohn RJ. Clinical and genetic aspects of distal myopathies. Muscle Nerve. 2001;24:1440-1450.
80. Linssen WH, Notermans NC, Vreyling JP, et al. Miyoshi-type distal muscular dystrophy. Clinical spectrum in 24 Dutch patients. Brain. 1997;120:1989-1996.
81. Shaibani A, Harati Y, Amato A, et al. Miyoshi myopathy with vacuoles. Neurology. 1997;47(suppl): A195.
82. McNally EM, Ly CT, Rosenmann H, et al. Splicing mutation in dysferlin produces limb-girdle muscular dystrophy with inflammation. Am J Med Genet. 2000;91:305-312.
83. Gallardo E, Rojas-García R, de Luna N, et al. Inflammation in dysferlin myopathy: Immunohistochemical characterization of 13 patients. Neurology. 2001;57:2136-2138.
84. Selcen D, Stilling G, Engel A. The earliest pathologic alterations in dysferlinopathy. Neurology. 2001; 56:1472-1481.
85. Piccolo F, Moore SA, Ford GC, et al. Intracellular accumulation and reduced sarcolemmal expression of dysferlin in limb-girdle muscular dystrophies. Ann Neurol. 2000;48:902-912.
86. Anderson LVB, Harrison RM, Pogue R, et al. Secondary reduction in calpain 3 expression in patients with limb girdle muscular dystrophy type 2B and Miyoshi myopathy (primary dysferlinopathies). Neuromuscul Disord. 2000;10:553-559.
87. Ho M, Gallardo E, McKenna-Yasek D, et al. A novel blood-based diagnostic assay for limb girdle muscular dystrophy type 2B and Miyoshi myopathy. Ann Neurol. 2002;51:129-133.
88. Leriche-Guérin K, Anderson LVB, Wrogemann K, et al. Dysferlin expression after normal myoblast transplantation in SCID and SJL mice. Neuromuscul Disord. 2002;12:167-173.
89. Ervasti JM, Campbell KP. A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J Cell Biol. 1993;122: 809-823.
90. Crosbie RH, Lim LE, Moore SA, et al. Molecular and genetic characterization of sarcospan: Insights into sarcoglycan-sarcospan interactions. Hum Mol Genet. 2000;9:2019-2027.
91. Merlini L, Kaplan J-C, Navarro C, et al. Homogeneous phenotype of the gypsy limb-girdle MD with the g-sarcoglycan C283Y mutation. Neurology. 2000;54:1075-1079.
92. McNally EM, Passos-Bueno, MR, Bönneman CG, et al. Mild and severe muscular dystrophy caused by a single γ-sarcoglycan mutation. Am J Hum Genet. 1996;59:1040-1047.
93. Mongini T, Doriguzzi C, Bosone I, et al. Alpha-sarcoglycan deficiency featuring exercise intolerance and myoglobinuria. Neuropediatrics. 2002; 33:109-111.
94. Cagliani R, Comi GP, Tancredi L, et al. Primary beta-sarcoglycanopathy manifesting as recurrent exercise-induced myoglobinuria. Neuromuscul Disord. 2001;11:389-394.
95. Politano L, Nigro V, Passamano L, et al. Evaluation of cardiac and respiratory involvement in sarcogly-canopathies. Neuromuscul Disord. 2001;11:178-185.
96. Barresi R, Moore SA, Stolle CA, et al. Expression of γ-sarcoglycan in smooth muscle and its interaction with the smooth muscle sarcoglycan-sarcospan complex. J Biol Chem. 2000;275:38554-38560.
97. Zimprich A, Grabowski M, Asmus F, et al. Mutations in the gene encoding E-sarcoglycan cause myoclonus-dystonia syndrome. Nat Genet. 2001;29: 66-69.
98. Tsubata S, Bowles KR, Vatta M, et al. Mutations in the human δ-sarcoglycan gene in familial and sporadic dilated cardiomyopathy. J Clin Invest. 2000; 106:655-662.
99. Vorgerd M, Glencik M, Mortier J, et al. Isolated loss of γ-sarcoglycan: Diagnostic implications in autosomal recessive limb-girdle muscular dystrophy. Muscle Nerve. 2001;24:421-424.
100. Vainzof M, Moreira ES, Canovas M, et al. Partial α-sarcoglycan deficiency with retention of the dystrophin-glycoprotein complex in a LGMD2D family. Muscle Nerve. 2000;23:984-988.
101. Allamand V, Donahue KM, Straub V, et al. Early adenovirus-mediated gene transfer effectively prevents muscular dystrophy in alpha-sarcoglycan-deficient mice. Gene Ther. 2000;7:1385-1391.
102. Cordier L, Hack AA, Scott MO, et al. Rescue of skeletal muscles of γ-sarcoglycan-deficient mice with adeno-associated virus-mediated gene transfer. Mol Ther. 2001:119-129.
103. Mendell JR, Stedman H, Moore SA, et al. Gene transfer clinical trial for limb girdle muscular dystrophy type 2D (alpha-sarcoglycan deficiency). Neurology. 2002;58(suppl 3):SA169.
104. Vainzof M, Moreira ES, Suzuki OT, et al. Telethonin protein expression in neuromuscular disorders. Biochim Biophys Acta. 2002;1588:33-40.
105. Moreira ES, Wiltshire TJ, Faulkner G, et al. Limb-girdle muscular dystrophy type 2G is caused by mutations in the gene encoding the sarcomeric protein telethonin. Nat Genet. 2000;24:163-166.
106. Knoll R, Hoshijima M, Hoffman HM, et al. The cardiac mechanical stretch sensor machinery involves a Z disc complex that is defective in a subset of human dilated cardiomyopathy. Cell. 2002;111: 943-955.
107. Moreira ES, Vainzof M, Marie SK, et al. The seventh form of autosomal recessive limb-girdle muscular dystrophy is mapped to 17q11-12. Am J Hum Genet. 1997;61:151-159.
108. Shokeir MHK, Kobrinsky NL. Autosomal recessive muscular dystrophy in Manitoba Hutterites. Clin Genet. 1976;9:197-202.
109. Weiler T, Greenberg CR, Zelinski T, et al. A gene for autosomal recessive limb-girdle muscular dystrophy in Manitoba Hutterites maps to chromosome region 9q31-q33: Evidence for another limb-girdle muscular dystrophy locus. Am J Hum Genet. 1998;63:140-147.
110. Frosk P, Weiler T, Nylen E, et al. Limb-girdle muscular dystrophy type 2H associated with mutation in TRIM32, a putative E3-ubiquitin-ligase gene. Am J Hum Genet. 2002;70:663-672.
111. Driss A, Amouri R, Ben Hamida C, et al. A new locus for autosomal recessive limb-girdle muscular dystrophy in a large consanguineous Tunisian family maps to chromosome 19q13.3. Neuromuscul Disord. 2000;10:240-246.
112. Brockington M, Blake DJ, Prandini P, et al. Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin α2 deficiency and abnormal glycosylation of α-dystroglycan. Am J Hum Genet. 2001;69:1198-1209.
113. Brockington M, Yuva Y, Prandini P, et al. Mutations in the fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 2I as a milder allelic variant of congenital muscular dystrophy MDC1C. Hum Mol Genet. 2001;10:2851-2859.
114. Driss A, Noguchi S, Amouri R, et al. Fukutin-related protein gene mutated in the original limb-girdle muscular dystrophy 2I. Neurology. 2003;60:1341-1344.
115. Poppe M, Cree L, Bourke J, et al. The phenotype of limb-girdle muscular dystrophy type 2I. Neurology. 2003;60:1246-1251.
116. Hein S, Schaper J. Weakness of a giant: Mutations of the sarcomeric protein titin. Trends Mol Med. 2002;8:311-313.
117. Hackman P, Vihola A, Haravuori H, et al. Tibial muscular dystrophy is a titinopathy caused by mutations in TIN, the gene encoding the giant skeletal muscle protein titin. Am J Hum Genet. 2002;71: 492-500.
118. Gerull B, Gramlich M, Atherton J, et al. Mutations of TIN, encoding the giant muscle filament titin, cause familial dilated cardiomyopathy. Nat Genet. 2002;30:201-204.
119. Udd B, Rapola J, Nokelainen P, et al. Nonvacuolar myopathy in a large family with both late adult onset distal myopathy and severe proximal muscular dystrophy. J Neurol Sci. 1992;113:214-221.
120. Haravuori H, Vihola A, Straub V, et al. Secondary calpain3 deficiency in 2q-linked muscular dystrophy: Titin is the candidate gene. Neurology. 2001; 56:869-877.
121. Garvey SM, Rajan C, Lerner AP, et al. The muscular dystrophy with myositis (mdm) mouse mutation disrupts a skeletal muscle-specific domain of titin. Genomics. 2002;79:146-149.
122. Anderson LVB, Bushby KMD, Hanna MG, et al. Diagnosing rare neuromuscular diseases-the jump from research to service. J Neurol Sci. 2002; 199(suppl):S72.
123. Stedman H, Wilson JM, Finke R, et al. Phase I clinical trial utilizing gene therapy for limb girdle muscular dystrophy: Alpha-, beta-, gamma-, or delta- sarcoglycan gene delivered with intramuscular instillations of adeno-associated vectors. Hum Gene Ther. 2000;11:777-790.
124. Skuk D, Vilquin JT, Tremblay JP. Experimental and therapeutic approaches to muscular dystrophies. Curr Opin Neurol. 2002;15:563-569.